{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T04:12:04Z","timestamp":1784347924773,"version":"3.55.0"},"reference-count":81,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T00:00:00Z","timestamp":1372896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Volume overload in heart failure (HF) results from neurohumoral activation causing renal sodium and water retention secondary to arterial underfilling. Volume overload not only causes signs and symptoms of congestion, but can impact myocardial remodeling and HF progression. Thus, treating congestion is a cornerstone of HF management. Loop diuretics are the most commonly used drugs in this setting. However, up to 30% of the patients with decompensated HF present with loop-diuretic resistance. A universally accepted definition of loop diuretic resistance, however, is lacking. Several approaches to treat diuretic-resistant HF are available, including addition of distal acting thiazide diuretics, natriuretic doses of mineralocorticoid receptor antagonists (MRAs), or vasoactive drugs. Slow continuous veno-venous ultrafiltration is another option. Ultrafiltration, if it is started early in the course of HF decompensation, may result in prominent decongestion and a reduction in re-hospitalization. On the other hand, ultrafiltration in HF patients with worsening renal function and volume overload after aggressive treatment with loop diuretics, failed to show benefit compared to a stepwise pharmacological approach, including diuretics and vasoactive drugs. Early detection of congested HF patients for ultrafiltration treatment might improve decongestion and reduce readmission. However, the best patient characteristics and best timing of ultrafiltration requires further evaluation in randomized controlled studies.<\/jats:p>","DOI":"10.3390\/ph6070851","type":"journal-article","created":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T03:53:40Z","timestamp":1372996420000},"page":"851-866","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Role of Diuretics and Ultrafiltration in Congestive Heart Failure"],"prefix":"10.3390","volume":"6","author":[{"given":"Dmitry","family":"Shchekochikhin","sequence":"first","affiliation":[{"name":"University of Colorado Division of Renal Diseases and Hypertension, 12700 East 19th Avenue, C281, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz","family":"Al Ammary","sequence":"additional","affiliation":[{"name":"University of Colorado Division of Renal Diseases and Hypertension, 12700 East 19th Avenue, C281, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Ann","family":"Lindenfeld","sequence":"additional","affiliation":[{"name":"University of Colorado Division of Renal Diseases and Hypertension, 12700 East 19th Avenue, C281, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schrier","sequence":"additional","affiliation":[{"name":"University of Colorado Division of Renal Diseases and Hypertension, 12700 East 19th Avenue, C281, Aurora, CO 80045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2013,7,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.108.191259","article-title":"Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Adams","year":"2009","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","article-title":"Rehospitalizations among patients in the Medicare fee-for-service program","volume":"360","author":"Jencks","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","article-title":"2009 focused update incorporated into the ACC\/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"53","author":"Hunt","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.09.011","article-title":"Congestion in acute heart failure syndromes: An essential target of evaluation and treatment","volume":"119","author":"Gheorghiade","year":"2006","journal-title":"Am. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/CIRCULATIONAHA.108.783910","article-title":"Transition from chronic compensated to acute decompensated heart failure: Pathophysiological insights obtained from continuous monitoring of intracardiac pressures","volume":"118","author":"Zile","year":"2008","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2011.07.022","article-title":"Left ventricular structural remodeling in health and disease: With special emphasis on volume, mass, and geometry","volume":"58","author":"Gaasch","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2005.07.067","article-title":"Role of diminished renal function in cardiovascular mortality: Marker or pathogenetic factor?","volume":"47","author":"Schrier","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","unstructured":"Linden, R.J., and Kappagoda, C.T. (1982). Atrial Receptors, Cambridge University Press."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.CIR.77.4.721","article-title":"Neurohormone interaction and adaptations in congestive HF","volume":"77","author":"Packer","year":"1988","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2215\/CJN.03150509","article-title":"CRS in Acute Decompensated HF","volume":"4","author":"Sarraf","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7326\/0003-4819-113-2-155","article-title":"Body fluid volume regulation in health and disease: A unifying hypothesis","volume":"113","author":"Schrier","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in HF","volume":"341","author":"Schrier","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.hfc.2008.03.006","article-title":"Renal hemodynamic changes in HF","volume":"4","author":"Blankstein","year":"2008","journal-title":"Heart. Fail. Clin."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Mechanisms of disease: Aldosterone in chronic HF","volume":"345","author":"Weber","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive HF","volume":"311","author":"Cohn","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_17","first-page":"F321","article-title":"Osmotic and nonosmotic control of vasopressin release","volume":"236","author":"Schrier","year":"1979","journal-title":"Am. J. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semnephrol.2011.09.003","article-title":"Update in diuretic therapy: Clinical pharmacology","volume":"31","author":"Brater","year":"2011","journal-title":"Semin. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ki.1979.120","article-title":"Pharmacodynamic analysis of the furosemide-probenecid interaction in man","volume":"6","author":"Chennavasin","year":"1979","journal-title":"Kidney Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/clpt.1980.111","article-title":"Renal tubular secretion and effects of furosemide","volume":"27","author":"Odlind","year":"1980","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_21","unstructured":"van Boxtel, C.J., Holford, N.H.G., and Danhof, M. (1992). The in vivo Study of Drug Action (Principles and Applications of Kinetic-Dynamic Modelling), Elsevier Science Publishers."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/j.1875-9114.1997.tb03681.x","article-title":"Variable furosemide absorption and poor predictability of response in elderly patients","volume":"17","author":"Murray","year":"1997","journal-title":"Pharmacotherapy"},{"key":"ref_23","first-page":"450","article-title":"Response of the kidney to furosemide (I. Effects of salt intake and renal compensation)","volume":"102","author":"Wilcox","year":"1983","journal-title":"J. Lab. Clin. Med."},{"key":"ref_24","first-page":"CD003178","article-title":"Continuous infusion versus bolus injection of loop diuretics in congestive heart failure","volume":"20","author":"Salvador","year":"2005","journal-title":"Cochrane Database Syst Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated HF","volume":"364","author":"Felker","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Heart Failure Society of America, Lindenfeld, J., Albert, N.M., Boehmer, J.P., Collins, S.P., Ezekowitz, J.A., Givertz, M.M., Katz, S.D., Klapholz, M., and Moser, D.K. (2010). Executive summary: HFSA 2010 comprehensive HF practice guidelines. J. Card Fail., 16, 475\u2013539.","DOI":"10.1016\/j.cardfail.2010.04.005"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1159\/000082314","article-title":"Long-term adaptation of renal ion transporters to chronic diuretic treatment","volume":"24","author":"Kim","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-114-10-886","article-title":"The physiologic basis of diuretic synergism: Its role in treating diuretic resistance","volume":"114","author":"Ellison","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00003088-199630030-00004","article-title":"Diuretic combinations in refractory oedema states: Pharmacokinetic-pharmacodynamic relationships","volume":"30","author":"Sica","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1527-5299.2003.01907.x","article-title":"Metolazone and its role in edema management","volume":"9","author":"Sica","year":"2003","journal-title":"Congest. Heart Fail."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/hrt.71.2.146","article-title":"Combination diuretic treatment in severe heart failure: A randomized controlled trial","volume":"71","author":"Channer","year":"1994","journal-title":"Br. Heart J."},{"key":"ref_33","first-page":"134","article-title":"Treatment of frusemide resistant edema with metolazone","volume":"4","author":"Asscher","year":"1974","journal-title":"Clin. Trials J."},{"key":"ref_34","first-page":"883","article-title":"Treatment of refractory congestive heart failure and normokalemic hypochloremic alkalosis with acetazolamide and spironolactone","volume":"123","author":"Khan","year":"1980","journal-title":"Can. Med. Assoc. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1164\/rccm.200507-1035OC","article-title":"Acetazolamide improves central sleep apnea in heart failure: A double-blind, prospective study","volume":"173","author":"Javaheri","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"For the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"EMPHASIS-HF Study Group Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"(1996). Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (The Randomized Aldactone Evaluation Study [RALES]). Am. J. Cardiol., 78, 902\u2013907.","DOI":"10.1016\/S0002-9149(96)00465-1"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"c1768","DOI":"10.1136\/bmj.c1768","article-title":"Spironolactone use and renal toxicity: Population based longitudinal analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000346447","article-title":"Increased Spironolactone in Advanced HF: Effect of Doses Greater Than 25 mg\/day on Plasma Potassium Concentration","volume":"3","author":"Shchekochikhin","year":"2013","journal-title":"Cardiorenal. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1161\/hc4501.099313","article-title":"Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure","volume":"104","author":"Udelson","year":"2001","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"For the SALT Investigators: Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/01.CIR.0000070422.41439.04","article-title":"Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: Results from a double-blind, randomized trial","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Acute and chronic therapeutic impact of a vasopressin antagonist in congestive heart failue (ACTIV in CHF) Investigators. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: A randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.jacc.2007.01.091","article-title":"Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction","volume":"49","author":"Udelson","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jacc.2008.08.013","article-title":"Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: An international, multicenter, randomized, placebo-controlled trial","volume":"52","author":"Udelson","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.semnephrol.2011.09.005","article-title":"Use of diuretics in heart failure and cirrhosis","volume":"31","author":"Schrier","year":"2011","journal-title":"Semin. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047397","article-title":"Diuretic therapy and resistance in congestive heart failure","volume":"96","author":"Ellison","year":"2001","journal-title":"Cardiology"},{"key":"ref_52","first-page":"F340","article-title":"Effect of furosemide on calcium and magnesium transport in the rat nephron","volume":"241","author":"Quamme","year":"1981","journal-title":"Am. J. Physiol."},{"key":"ref_53","unstructured":"(2002). Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestiveheart failure: A randomized controlled trial. JAMA, 287, 1531\u20131540."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","article-title":"Sodium retention in heart failure and cirrhosis: Potential role of natriuretic doses of mineralocorticoid antagonist?","volume":"2","author":"Bansal","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005344-199703000-00010","article-title":"Sequential Nephron Blockade Breaks Resistance to Diuretics in Edematous States","volume":"29","author":"Knauf","year":"1997","journal-title":"J. Cardiovasc. Pharm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000176458","article-title":"Diuretic Resistance: Mechanisms and Therapeutic Strategies","volume":"84","author":"Brater","year":"1994","journal-title":"Cardiology"},{"key":"ref_57","unstructured":"Puschett, J.B., and Greenberg, A. (1993). Diuretics IV, Chemistry, Pharmacology and Clinical Applictions, Excerpta Medica pupl."},{"key":"ref_58","unstructured":"Seldin, D.W., and Giebisch, G. (1990). The Regulation of Sodium and Chloride Balance, Raven Press."},{"key":"ref_59","unstructured":"Puschett, J.B., and Greenberg, A. (1989). Diuretics III, Chemistry, Pharmacology, and Clinical Applications, Elsevier."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198810203191606","article-title":"Pathogenesis of sodium and water retention in high and low output cardiac failure, cirrhosis, nephrotic syndrome, and pregnancy","volume":"319","author":"Schrier","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1172\/JCI113847","article-title":"Adaption of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion","volume":"83","author":"Ellison","year":"1989","journal-title":"J. Clin. Invest."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"R459","DOI":"10.1152\/ajpregu.2001.281.2.R459","article-title":"Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure","volume":"281","author":"Gabrielsen","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jhep.2001.20646","article-title":"Furosemide-Induced Natriuresis as a Test To Identify Cirrhotic Patients With Refractory Ascites","volume":"33","author":"Spahr","year":"2001","journal-title":"Hepatology"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/archinte.1980.00330160091033","article-title":"Low fractional excretion of sodium with contrast media-induced acute renal failure","volume":"140","author":"Fang","year":"1980","journal-title":"Arch. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJM197410102911501","article-title":"Treatment of severe fluid overload by ultrafiltration","volume":"291","author":"Silverstein","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jacc.2005.05.098","article-title":"Ultrafiltration versus usual care for hospitalized patients with heart failure: The Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial","volume":"46","author":"Bart","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/hrt.70.2.135","article-title":"Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: Pathophysiological correlates","volume":"70","author":"Pepi","year":"1993","journal-title":"Br. Heart J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1054\/jcaf.2003.28","article-title":"Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients","volume":"9","author":"Jaski","year":"2003","journal-title":"J. Card. Fail."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0735-1097(93)90685-T","article-title":"Isolated ultrafiltration in moderate congestive heart failure","volume":"21","author":"Agostoni","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2005.05.099","article-title":"Early ultrafiltration in patients with decompensated heart failure and diuretic resistance","volume":"46","author":"Costanzo","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cardfail.2007.09.007","article-title":"A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure","volume":"14","author":"Rogers","year":"2008","journal-title":"J. Card. Fail."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated HF","volume":"49","author":"Constanzo","year":"2007","journal-title":"J. Am. Coll. Card."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cardfail.2009.12.009","article-title":"Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: Results from UNLOAD","volume":"16","author":"Costanzo","year":"2010","journal-title":"J. Card. Fail."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0002-9343(93)90119-A","article-title":"Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive HF: Effects of extracorporeal ultrafiltration","volume":"94","author":"Marenzi","year":"1993","journal-title":"Am. J. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jacc.2012.08.957","article-title":"Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure","volume":"60","author":"Patarroyo","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated HF with CRS","volume":"367","author":"Bart","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cardfail.2010.02.001","article-title":"The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated HF","volume":"16","author":"Aronson","year":"2010","journal-title":"J. Card. Fail."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000417488","article-title":"Effects of ultrafiltration of body fluid and transcapillary colloid osmotic gradient in hemodialysis patients, improvements in dialysis therapy","volume":"74","author":"Fauchauld","year":"1989","journal-title":"Contrib. Nephr."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ahj.2010.09.014","article-title":"Ultrafiltration in heart failure","volume":"161","author":"Fiaccadori","year":"2011","journal-title":"Am. Heart J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3747\/pdi.2012.00014","article-title":"Nonuremic indication for peritoneal dialysis for refractory heart failure in cardiorenal syndrome type II: Review and perspective","volume":"33","author":"Nakayama","year":"2013","journal-title":"Perit. Dial. Int."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5301\/jn.5000288","article-title":"Ultrafiltration in acute decompensated heart failure: Friend or foe for the kidney?","volume":"26","author":"Regolisti","year":"2013","journal-title":"J. Nephrol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/6\/7\/851\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:47:44Z","timestamp":1760219264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/6\/7\/851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,4]]},"references-count":81,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7]]}},"alternative-id":["ph6070851"],"URL":"https:\/\/doi.org\/10.3390\/ph6070851","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,4]]}}}